Skip to main content
. 2019 Jun 7;7:148. doi: 10.1186/s40425-019-0619-8

Fig. 6.

Fig. 6

Proposed scheme for combination biomarkers to stratify MIUC patients for chemo-immunotherapy. Tumor mRNA subtype, DDR mutation status and immunoregulatory gene expression levels should be included in one combination biomarker assay to select patients for chemo-immunotherapy. Image design by http://www.designsthatcell.ca/